Disease-linked inner mitochondrial membrane protein MPV17 - causes MDDS
Mitochondrial DNA Depletion Syndrome (MDDS) is a group of rare genetic disorders characterized by a significant reduction in mitochondrial DNA (mtDNA) copy number, leading to impaired energy production in cells. This condition manifests in various tissues, especially those with high energy demands, such as the brain, liver, and muscles, and can result in severe clinical symptoms including muscle weakness, neurological deficits, liver failure, and early mortality.
MPV17 is a mitochondrial inner membrane protein that plays a crucial role in maintaining mtDNA integrity and homeostasis. Although the precise functions of MPV17 are not fully understood, mutations in the MPV17 gene are known to cause a specific form of MDDS, primarily affecting the liver and nervous system. This suggests that MPV17 is essential for the normal maintenance and replication of mitochondrial DNA. Ongoing research aims to fully characterize MPV17's functional and structural roles to understand better its involvement in mitochondrial pathophysiology and its potential as a therapeutic target for MDDS.
Mutations in MDDS in MPV17
Hattab.et.al.2017
Despite extensive research, the MPV17 protein is not yet fully characterized. To address this, studies will investigate its functional roles by examining mitochondrial structural changes upon MPV17 deletion, the impact of reactive oxygen species on its functionality, and its structural details using advanced techniques like
TEM
2. cryo-EM
3. NMR
These efforts aim to understand MPV17's role in cellular processes comprehensively.
REFERENCES
1. Dyall, S. D., Brown, M. T., and Johnson, P. J. (2004) Ancient invasions: from
endosymbionts to organelles. Science 304, 253–257 CrossRef Medline
2. Andersson, S. G., Karlberg, O., Canback, B., and Kurland, C. G. (2003) On the origin of
mitochondria: a genomics perspective. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 358,
165–177; discussion 177–179 CrossRef Medline
3. Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H., Coulson, A. R., Drouin, J.,
Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., Schreier, P. H., Smith, A. J., Staden, R.,
and Young, I. G. (1981) Sequence and organization of the human mitochondrial genome.
Nature 290, 457–465 CrossRef Medline
4. Foury, F., Roganti, T., Lecrenier, N., and Purnelle, B. (1998) The complete sequence of the
mitochondrial genome of Saccharomyces cerevisiae. FEBS Lett. 440, 325–331 CrossRef
Medline
5. Weiher H, Noda T, Gray DA, Sharpe AH, Jaenisch R. Transgenic mouse model of kidney
disease: insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome.
Cell. 1990;62:425–34.
6. El-Hattab AW, Wang J, Dai H, Almannai M, Scaglia F, Craigen WJ. MPV17-related
mitochondrial DNA maintenance defect. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE,
Bean LJH, Stephens K, et al. editors. GeneReviews((R)). Seattle, WA, University of
Washington Press publisher; 1993.
7. Sarzi E, Bourdon A, Chrétien D, Zarhrate M, Corcos J, Slama A, et al. Mitochondrial DNA
depletion is a prevalent cause of multiple respiratory chain deficiency in childhood. J Pediatr.
2007;150:531–4. 534 e531-536
8. Spinazzola A, Massa V, Hirano M, Zeviani M. Lack of a founder effect for an identical
mtDNA depletion syndrome (MDS)-associated MPV17 mutation shared by Navajos and
Italians. Neuromuscul Disord. 2008;18:315–8.
9. AlSaman A, Tomoum H, Invernizzi F, Zeviani M. Hepatocerebral form of mitochondrial
DNA depletion syndrome due to mutation in MPV17 gene. Saudi J Gastroenterol.
2012;18:285–9.
10. Mudd SH, Wagner C, Luka Z, Stabler SP, Allen RH, Schroer R, et al. Two patients with
hepatic mtDNA depletion syndromes and marked elevations of S-adenosylmethionine and
methionine. Mol Genet Metab. 2012;105: 228–36.
11. Kim J, Kang E, Kim Y, Kim JM, Lee BH, Murayama K, et al. MPV17 mutations in patients
with hepatocerebral mitochondrial DNA depletion syndrome. Mol GenetMetab Rep.2016;8:74–76.
Comments